Literature DB >> 24895042

Clinical implication of fasting and post-challenged plasma glucose in diagnosis of diabetes mellitus.

Jean Huang1, Horng-Yih Ou, Rudruidee Karnchanasorn, Raynald Samoa, Lee-Ming Chuang, Ken C Chiu, Wei Feng.   

Abstract

Fasting plasma glucose (FPG) is the preferred test in diagnosis of diabetes mellitus (DM) to 2-h post-challenged plasma glucose (2hPG). There is little information available on the comparison between FPG and 2hPG diagnostic criteria. This study included adult participants (≥18 years old) of the NHANES 2005-2010 with FPG, 2hPG, and BMI measured. Subjects with established DM were excluded. The sensitivity of FPG and 2hPG diagnostic criteria was compared as the main outcome measure. Among 5,782 subjects, 476 subjects (8.23 %) were diagnosed with DM by either FPG, 2hPG, or both criteria. Among the subjects meeting the criterion of FPG, those with 2hPG <200 mg/dL were younger (57 ± 16 vs. 61 ± 15 years old, P < 0.05, mean ± STD) and less obese (30.81 ± 7.89 vs. 32.71 ± 6.68 kg/m(2), P < 0.05) as compared to those with 2hPG ≥200 mg/dL. Among the subjects meeting the criterion of 2hPG, those with FPG <126 mg/dL were more female (55.41 vs. 39.88 %, P < 0.0002), less obese (29.24 ± 5.83 vs. 32.71 ± 6.68 kg/m(2), P < 0.000001), lower diastolic blood pressure (67 ± 12 vs. 71 ± 14 mmHg, P < 0.02), and less family history of DM (36.35 vs. 48.47 %, P < 0.02) as compared to those with FPG ≥126 mg/dL. The sensitivity of diagnosis of DM was only 41.37 % for FPG criterion, while it was 66.53 % for 2hPG criterion. Thus, compared to 2hPG criterion, FPG criterion had a lower sensitivity detecting new cases of DM. The use of FPG criterion would more likely result in underdiagnosing DM, especially in female and less obese subjects, as compared to the use of 2hPG criterion.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24895042     DOI: 10.1007/s12020-014-0301-3

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  24 in total

1.  The prevalence of retinopathy in impaired glucose tolerance and recent-onset diabetes in the Diabetes Prevention Program.

Authors: 
Journal:  Diabet Med       Date:  2007-02       Impact factor: 4.359

2.  Utility of A1C for diabetes screening in the 1999 2004 NHANES population.

Authors:  Catherine Buell; Duclie Kermah; Mayer B Davidson
Journal:  Diabetes Care       Date:  2007-06-11       Impact factor: 19.112

3.  Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans.

Authors:  Christian Meyer; Walkyria Pimenta; Hans J Woerle; Timon Van Haeften; Ervin Szoke; Asimina Mitrakou; John Gerich
Journal:  Diabetes Care       Date:  2006-08       Impact factor: 19.112

4.  Are current diagnostic guidelines delaying early detection of dysglycemic states? Time for new approaches.

Authors:  Michael Bergman; Rachel Dankner; Jesse Roth; K M Venkat Narayan
Journal:  Endocrine       Date:  2013-01-17       Impact factor: 3.633

5.  Is the measurement of glycated hemoglobin A1c alone an efficient screening test for undiagnosed diabetes? Japan National Diabetes Survey.

Authors:  Tomoko Nakagami; Makoto Tominaga; Rimei Nishimura; Nobuo Yoshiike; Makoto Daimon; Toshihide Oizumi; Naoko Tajima
Journal:  Diabetes Res Clin Pract       Date:  2006-10-17       Impact factor: 5.602

6.  Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance.

Authors:  C Weyer; C Bogardus; R E Pratley
Journal:  Diabetes       Date:  1999-11       Impact factor: 9.461

7.  The onset of NIDDM and its relationship to clinical diagnosis in Egyptian adults.

Authors:  T J Thompson; M M Engelgau; M Hegazy; M A Ali; E S Sous; A Badran; W H Herman
Journal:  Diabet Med       Date:  1996-04       Impact factor: 4.359

8.  Short-term variability in measures of glycemia and implications for the classification of diabetes.

Authors:  Elizabeth Selvin; Ciprian M Crainiceanu; Frederick L Brancati; Josef Coresh
Journal:  Arch Intern Med       Date:  2007-07-23

9.  Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group.

Authors: 
Journal:  Diabetes       Date:  1979-12       Impact factor: 9.461

Review 10.  The critical role of metabolic pathways in aging.

Authors:  Nir Barzilai; Derek M Huffman; Radhika H Muzumdar; Andrzej Bartke
Journal:  Diabetes       Date:  2012-06       Impact factor: 9.461

View more
  2 in total

1.  Clinical Implications of Using Post-Challenge Plasma Glucose Levels for Early Diagnosis of Type 2 Diabetes Mellitus in Older Individuals.

Authors:  Kyong Hye Joung; Sang Hyun Ju; Ji Min Kim; Sorim Choung; Jae Min Lee; Kang Seo Park; Hyun Jin Kim; Bon Jeong Ku
Journal:  Diabetes Metab J       Date:  2018-04       Impact factor: 5.376

2.  Diagnostic accuracy of tests for type 2 diabetes and prediabetes: A systematic review and meta-analysis.

Authors:  Gunjeet Kaur; P V M Lakshmi; Ashu Rastogi; Anil Bhansali; Sanjay Jain; Yot Teerawattananon; Henna Bano; Shankar Prinja
Journal:  PLoS One       Date:  2020-11-20       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.